Lactose Segmentation
Pharmaceutical Grade (Inhalation Grade, Parenteral Grade, Oral Solid Dose (OSD))
The inhalation grade segment is projected to gain about 35.9% lactose market share through 2037. The increasing growth of pulmonary medication delivery systems for the treatment of TB, COPD, and asthma will lead to the dominance of inhalation-grade lactose. Over 262 million people worldwide are estimated by the World Health Organization (WHO) to have COPD, and there is a significant demand for dry powder inhalers (DPIs), which use lactose as a carrier. The WHO's Global Tuberculosis Report (2023) also notes a rise in multidrug-resistant TB patients, which increases the need for drug delivery that is facilitated by DPI.
Food Grade (Bakery & Confectionery, Dairy Products, Savory Snacks)
The use of lactose as a natural sweetener and texture enhancer in baked goods and confections is being driven by the rise in processed food consumption, particularly in emerging economies. Lactose consumption in this category is being driven by the growing desire for inexpensive, high-energy snack foods, according to the U.S. Department of Agriculture (USDA). Global confectionery sales are increasing, according to the National Confectioners Association (NCA), and lactose is frequently utilized in formulations with less sugar.
Our in-depth analysis of the global lactose market includes the following segments:
|
Pharmaceutical Grade |
|
|
Food Grade |
|
|
Infant Formula Grade |
|
|
Industrial Grade
|
|
|
Nutraceuticals |
|
|
Animal Feed |
|
